Target Corporation (TGT)

Total Liabilities

$43.39B

Quarterly · Period ending: · USD

TGT logo

TGT Total Liabilities

Latest reported$43.39B
TGT Quarterly Total Liabilities ($2.47B → $43.39B)
High-resolution chart · PNG

TGT total liabilities history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Target Corporation Total Liabilities — Quarterly (USD)
Period endingTotal Liabilities (USD)
43,392,000,000
41,615,000,000
43,325,000,000
44,490,000,000
42,431,000,000
41,238,000,000
43,103,000,000
44,042,000,000
41,566,000,000
41,277,000,000
41,924,000,000
43,715,000,000
41,216,000,000
40,545,000,000
42,103,000,000
44,596,000,000
41,878,000,000
40,068,000,000
40,984,000,000
40,608,000,000
36,525,000,000
35,512,000,000
36,808,000,000
37,342,000,000
35,422,000,000
33,637,000,000
30,946,000,000
32,196,000,000
29,730,000,000
29,502,000,000
29,993,000,000
32,492,000,000
28,829,000,000
27,771,000,000
28,652,000,000
29,571,000,000
26,268,000,000
26,197,000,000
26,478,000,000
27,534,000,000
25,711,000,000
27,363,000,000
27,305,000,000
28,440,000,000
26,444,000,000
26,272,000,000
27,175,000,000
30,088,000,000
28,022,000,000
27,556,000,000
28,322,000,000
30,217,000,000
28,142,000,000
27,714,000,000
31,605,000,000
33,227,000,000
31,428,000,000
30,312,000,000
30,809,000,000
33,183,000,000
30,393,000,000
27,766,000,000
28,218,000,000
30,070,000,000
28,387,000,000
27,726,000,000
29,186,000,000
31,008,000,000
29,631,000,000
30,093,000,000
30,394,000,000
33,461,000,000
31,683,000,000
28,473,000,000
29,253,000,000
27,129,000,000
23,512,000,000
22,573,000,000
21,716,000,000
23,067,000,000
21,050,000,000
20,379,000,000
20,790,000,000
20,942,000,000
18,397,000,000
18,248,000,000
19,264,000,000
19,388,000,000
18,929,000,000
19,660,000,000
20,327,000,000
21,159,000,000
19,590,000,000
19,412,000,000
19,160,000,000
19,919,000,000
18,742,000,000
16,995,000,000
16,294,000,000
16,704,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.